Author: Bella Hayes
New York, New York–(Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Transocean Ltd . (NYSE: NYSE:) between October 31, 2023 and September 2, 2024, both dates inclusive (the “Class Period”), of the important February 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Transocean securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Transocean class action, go to https://rosenlegal.com/submit-form/?case_id=32789 or call…
New York, New York–(Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Light & Wonder, Inc. (NASDAQ: NASDAQ:) resulting from allegations that Light & Wonder may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Light & Wonder securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT…
In recent financial news, Representative Michael Waltz from Florida’s 6th congressional district has made notable transactions in BoodleAI, a leading company in artificial intelligence technology. The transactions took place on December 24, 2024, and were reported to authorities on December 27, 2024, as per the Periodic Transaction (JO:) Report. The AI sector has seen significant growth, with major publicly traded AI companies tracked on InvestingPro showing an average revenue growth of over 25% in the past year. The transactions were twofold, both involving the same amount in the range of $50,001 to $100,000. The first transaction was a Simple Agreement…
New York, New York–(Newsfile Corp. – January 25, 2025) – Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether TransMedics Group (NASDAQ:), Inc. (“TransMedics Group” or the “Company”) (NASDAQ: ™DX) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws.CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION TransMedics Group operates an organ transplant ecosystem under which it offers patented technology to preserve and mobilize organs, services that support transplant centers and medical teams, and…
Radnor, Pennsylvania–(Newsfile Corp. – January 25, 2025) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics (NASDAQ:), Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Applied Therapeutics losses, you may CLICK…
NEW YORK – January 25, 2025 (NEWMEDIAWIRE) – Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics (NASDAQ:), Inc. (Applied Therapeutics or the Company) (NASDAQ: APLT) on behalf of investors that purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024 (the Class Period). CLICK HERE TO JOIN THE CASE If you are an investor in Applied Therapeutics and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing jcampisi@kaplanfox.com or by calling (212) 329-8571. DEADLINE REMINDER: If you…
New York, New York–(Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Dave Inc. (NASDAQ: DAVE) resulting from allegations that Dave may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Dave securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the…
New York, New York–(Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call…
Readout of ~1K patients at ASCO GI 2025 demonstrates that Signatera™ positive patients treated with both chemotherapy and celecoxib had a 40% improvement in overall survival versus chemotherapy aloneAdditional ASCO GI poster highlights data from the ALTAIR clinical trial, showing significant clinical benefit in patients with stage IV colorectal cancer who were treated with Trifluridine/Tipiracil (FTD/TPI) AUSTIN, Texas,–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced new data from the randomized, Phase III CALGB (Alliance) / SWOG 80702 study. The study will be presented today, Jan. 25, 2025 as a late-breaking oral presentation at…
New York, New York–(Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: NYSE:) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Customers Bancorp securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join…
